Mexican Americans and non-Hispanic Whites born in the United States have a higher risk for developing psychiatric disorders

According to the results of a National Institutes of Health (NIH) study, reported in the December issue of the Archives of General Psychiatry, Mexican Americans and non-Hispanic Whites born in the United States have a higher risk for developing psychiatric disorders than their foreign-born counterparts who have immigrated to the United States.

The psychiatric disorders included alcohol and drug use disorders, major depression, dysthymia, mania, hypomania, panic disorder, social and specific phobia, and general anxiety disorder.

Based on the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), the analysis is the first to consider immigration status in conjunction with psychiatric morbidity in each of four comparison groups: U.S.-born Mexican Americans, Mexican immigrants to the United States, U.S.-born non-Hispanic Whites, and non-Hispanic White immigrants to the United States. Earlier studies compared psychiatric disorder rates among U.S.- and foreign-born Mexican Americans to either rates for U.S.-born non-Hispanic Whites or rates for the entire U.S. population, thereby confounding immigration status and ethnicity.

"The remarkable pattern seen in these results defies explanation based on current knowledge," according to George Kunos, M.D., Ph.D., Scientific Director, Division of Intramural Biological and Clinical Research at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the NIH institute that conducted the study. "Additional careful research is required to understand the influences of individual and environmental factors in the causes of psychiatric disorders."

"As often occurs, our epidemiologists-researchers who study conditions and behaviors across large population groups-pose new and intriguing questions for researchers in other disciplines," he said. "Although it may be some time before scientists fully understand the causes of these disorders, service providers and policy makers have immediate use for the results."

Lead author Bridget Grant, Ph.D., Chief of the Laboratory of Biometry and Epidemiology in NIAAA's intramural research program, and her colleagues found that non-Hispanic Whites' lifetime rate of experiencing a psychiatric disorder (51.2 percent) was far greater overall than that for all Mexican Americans (36.7 percent). Psychiatric disorders were more prevalent among U.S.-born survey participants (47.6 percent among Mexican Americans and 52.5 percent among non-Hispanic Whites) than among their foreign-born counterparts (28.5 percent and 32.3 percent, respectively). Lifetime rates of alcohol use disorder and specific mood and anxiety disorder among U.S.-born Mexican Americans and non-Hispanic Whites were nearly twice those of their foreign-born counterparts. Drug use disorder rates among U.S.-born non-Hispanic Whites were more than twice those of their foreign-born counterparts, whereas the corresponding rates among U.S.-born Mexican Americans (12 percent) were eight times those of Mexican Americans born outside the United States (1.7 percent).

After controlling for age, sex, marital status, place of residence, geographic region, education, and family income, the authors examined relationships among the four comparison groups and each psychiatric disorder. They determined that, with few exceptions, risk for all the psychiatric disorders assessed was significantly greater among U.S.-born than foreign-born non-Hispanic Whites and among U.S.-born than foreign-born Mexican Americans.

"Foreign-born study participants were at lower risk of major psychiatric disorders even though they may have experienced greater stress due to low socioeconomic status or adapting to a new culture," noted Dr. Grant. "This is consistent with the 'healthy migrant' model that predicts that foreign-born persons in good health are more likely than those in poor health to immigrate to the United States. However, this hypothesis does not explain the study's finding that risk for drug dependence and specific mood and anxiety disorders was similar among foreign-born non-Hispanic Whites and U.S.-born Mexican Americans." Also weighing against the healthy migrant model, the authors report, is the fact that psychiatric disorder rates among foreign-born Mexican American immigrants are similar to but not lower than rates in Mexico City.

The study findings suggest that acculturation has negative effects on the mental health of both Mexican Americans and non-Hispanic Whites and that cultural retention (i.e., the preservation of traditional family networks and customs) has protective effects on the mental health of Mexican Americans, according to the authors: "While foreign-born Mexican Americans and non-Hispanic Whites did not differ in the risk of psychiatric disorders, U.S.-born Mexican Americans had a clear advantage over U.S.-born non-Hispanic Whites."

Identifying the specific components of various cultures that may reduce possible negative effects of acculturation on mental health or protect against psychopathology holds great promise in helping to guide future prevention and treatment efforts, the authors conclude.

Comments

  1. Terry Walker Terry Walker Canada says:

    When you give atypical antipsychotic or atypical antidepressants to a healthy person you cause psychiatric disorders that the drugs were intended to mask; it starts with the first pill! I will never forget that first paxil pill; what a rush! Malignant neoplasms brain is what one year of paxil left me with; I'm white with native ancestry from Kahnawake, Quebec, Canada.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oral medication sodium oxybate shows promise for treating laryngeal dystonia